Hartwig Huland

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Budäus Lars; Isbarn Hendrik; Schlomm Thorsten; Heinzer Hans; Haese Alexander; Steuber Thomas; Salomon Georg; Huland Hartwig; Graefen Markus
Current technique of open intrafascial nerve-sparing retropubic prostatectomy.
Adam Christoph; Salomon Georg; Walther Sebastian; Zaak Dirk; Khoder Wael; Becker Armin; Reich Oliver; Blana Andreas; Ganzer Roman; Denzinger Stefan; Popken Gralf; Sroka Ronald; Knüchel-Clarke Ruth; Köllermann Jens; Sauter Guido; Hartmann Arndt; Bertz Simone; Graefen Markus; Huland Hartwig; Wieland Wolf; Stief Christian G
Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
Fleischmann Achim; Schlomm Thorsten; Köllermann Jens; Sekulic Nikolina; Huland Hartwig; Mirlacher Martina; Sauter Guido; Simon Ronald; Erbersdobler Andreas
Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hartwig Huland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Budäus Lars; Isbarn Hendrik; Schlomm Thorsten; Heinzer Hans; Haese Alexander; Steuber Thomas; Salomon Georg; Huland Hartwig; Graefen Markus
Current technique of open intrafascial nerve-sparing retropubic prostatectomy.
European urology 2009;56(2):317-24.
2009: Adam Christoph; Salomon Georg; Walther Sebastian; Zaak Dirk; Khoder Wael; Becker Armin; Reich Oliver; Blana Andreas; Ganzer Roman; Denzinger Stefan; Popken Gralf; Sroka Ronald; Knüchel-Clarke Ruth; Köllermann Jens; Sauter Guido; Hartmann Arndt; Bertz Simone; Graefen Markus; Huland Hartwig; Wieland Wolf; Stief Christian G
Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
European urology 2009;55(6):1281-8.
2009: Fleischmann Achim; Schlomm Thorsten; Köllermann Jens; Sekulic Nikolina; Huland Hartwig; Mirlacher Martina; Sauter Guido; Simon Ronald; Erbersdobler Andreas
Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
The Prostate 2009;69(9):976-81.
2009: Helo Pauliina; Cronin Angel M; Danila Daniel C; Wenske Sven; Gonzalez-Espinoza Rita; Anand Aseem; Koscuiszka Michael; Väänänen Riina-Minna; Pettersson Kim; Chun Felix K-H; Steuber Thomas; Huland Hartwig; Guillonneau Bertrand D; Eastham James A; Scardino Peter T; Fleisher Martin; Scher Howard I; Lilja Hans
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
Clinical chemistry 2009;55(4):765-73.
2009: Schlomm Thorsten; Hellwinkel Olaf J C; Buness Andreas; Ruschhaupt Markus; Lübke Andreas M; Chun Felix K; Simon Ronald; Budäus Lars; Erbersdobler Andreas; Graefen Markus; Huland Hartwig; Poustka Annemarie; Sültmann Holger
Molecular cancer phenotype in normal prostate tissue.
European urology 2009;55(4):885-90.
2009: Isbarn Hendrik; Jeldres Claudio; Budäus Lars; Salomon Georg; Schlomm Thorsten; Steuber Thomas; Chun Felix K H; Ahyai Sascha; Capitanio Umberto; Haese Alexander; Heinzer Hans; Huland Hartwig; Graefen Markus; Karakiewicz Pierre
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
Urology 2009;73(3):615-9.
2009: Ahyai Sascha A; Eichelberg Christian; Isbarn Hendrik; Zacharias Mario; Briganti Alberto; Huland Hartwig; Chun Felix K-H
Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
European urology 2009;55(3):607.
2009: Chun Felix K-H; Suardi Nazareno; Capitanio Umberto; Jeldres Claudio; Ahyai Sascha; Graefen Markus; Haese Alexander; Steuber Thomas; Erbersdobler Andreas; Montorsi Francesco; Huland Hartwig; Karakiewicz Pierre I
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):617-28-6.
2009: Salomon Georg; Isbarn Hendrik; Budaeus Lars; Schlomm Thorsten; Briganti Alberto; Steuber Thomas; Heinzer Hans; Haese Alexander; Graefen Markus; Karakiewicz Pierre I; Huland Hartwig; Chun Felix
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
The journal of sexual medicine 2009;6(2):498-504.
2009: Walz Jochen; Chun Felix K-H; Klein Eric A; Reuther Alwyn; Saad Fred; Graefen Markus; Huland Hartwig; Karakiewicz Pierre I
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
The Journal of urology 2009;181(2):601-7; discussion 607-8.
2009: Walz Jochen; Chun Felix K H; Klein Eric A; Reuther Alwyn; Graefen Markus; Huland Hartwig; Karakiewicz Pierre I
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
European urology 2009;55(2):412-19.
2009: Bhojani N; Ahyai S; Graefen M; Capitanio U; Suardi N; Shariat S F; Jeldres C; Erbersdobler A; Schlomm T; Haese A; Steuber T; Heinzer H; Montorsi F; Huland H; Karakiewicz P I
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):123-8.
2009: Isbarn Hendrik; Ahyai Sascha A; Chun Felix K H; Budäus Lars; Schlomm Thorsten; Salomon Georg; Zacharias Mario; Erbersdobler Andreas; Köllermann Jens; Sauter Guido; Huland Hartwig; Graefen Markus; Steuber Thomas
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
European urology 2009;55(2):394-401.
2009: Salomon Georg; Hess Thorsten; Erbersdobler Andreas; Eichelberg Christian; Greschner Siegfried; Sobchuk Andrey N; Korolik Anna K; Nemkovich Nicolai A; Schreiber Jürgen; Herms Martin; Graefen Markus; Huland Hartwig
The feasibility of prostate cancer detection by triple spectroscopy.
European urology 2009;55(2):376-83.
2008: Fleischmann Achim; Schlomm Thorsten; Huland Hartwig; Köllermann Jens; Simon Philipp; Mirlacher Martina; Salomon Georg; Chun Felix H K; Steuber Thomas; Simon Ronald; Sauter Guido; Graefen Markus; Erbersdobler Andreas
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7838-42.
2008: Capitanio Umberto; Ahyai Sasha; Graefen Markus; Jeldres Claudio; Shariat Shahrokh F; Erbersdobler Andreas; Schlomm Thorsten; Haese Alexander; Steuber Thomas; Heinzer Hans; Perrotte Paul; Péloquin François; Pharand Daniel; Arjane Philippe; Huland Hartwig; Karakiewicz Pierre I
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: Eichelberg Christian; Heuer Roman; Chun Felix K; Hinrichs Kristin; Zacharias Mario; Huland Hartwig; Heinzer Hans
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis.
European urology 2008;54(6):1373-8.
2008: Salomon Georg; Köllerman Jens; Thederan Imke; Chun Felix K H; Budäus Lars; Schlomm Thorsten; Isbarn Hendrik; Heinzer Hans; Huland Hartwig; Graefen Markus
Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.
European urology 2008;54(6):1354-62.
2008: Köllermann Jens; Schlomm Thorsten; Bang Holger; Schwall Gerhard P; von Eichel-Streiber Christoph; Simon Ronald; Schostak Martin; Huland Hartwig; Berg Wigbert; Sauter Guido; Klocker Helmut; Schrattenholz André
Expression and prognostic relevance of annexin A3 in prostate cancer.
European urology 2008;54(6):1314-23.
2008: Jeldres Claudio; Suardi Nazareno; Walz Jochen; Hutterer Georg C; Ahyai Sascha; Lattouf Jean-Baptiste; Haese Alexander; Graefen Markus; Erbersdobler Andreas; Heinzer Hans; Huland Hartwig; Karakiewicz Pierre I
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
European urology 2008;54(6):1306-13.
2008: Walz Jochen; Haese Alexander; Scattoni Vincenzo; Steuber Thomas; Chun Felix K H; Briganti Alberto; Montorsi Francesco; Graefen Markus; Huland Hartwig; Karakiewicz Pierre I
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
Cancer 2008;113(10):2695-703.
2008: Fischer Nicole; Hellwinkel Olaf; Schulz Claudia; Chun Felix K H; Huland Hartwig; Aepfelbacher Martin; Schlomm Thorsten
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2008;43(3):277-83.
2008: Haese Alexander; de la Taille Alexandre; van Poppel Hendrik; Marberger Michael; Stenzl Arnulf; Mulders Peter F A; Huland Hartwig; Abbou Clément-Claude; Remzi Mesut; Tinzl Martina; Feyerabend Susan; Stillebroer Alexander B; van Gils Martijn P M Q; Schalken Jack A
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
European urology 2008;54(5):1081-8.
2008: Suardi Nazareno; Capitanio Umberto; Chun Felix K H; Graefen Markus; Perrotte Paul; Schlomm Thorsten; Haese Alexander; Huland Hartwig; Erbersdobler Andreas; Montorsi Francesco; Karakiewicz Pierre I
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
Cancer 2008;113(8):2068-72.
2008: Chun Felix K-H; Haese Alexander; Ahyai Sascha A; Walz Jochen; Suardi Nazareno; Capitanio Umberto; Graefen Markus; Erbersdobler Andreas; Huland Hartwig; Karakiewicz Pierre I
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
Cancer 2008;113(4):701-9.
2008: Schwarzenbach Heidi; Chun Felix K-H; Müller Imke; Seidel Christoph; Urban Karoline; Erbersdobler Andreas; Huland Hartwig; Pantel Klaus; Friedrich Martin G
Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
BJU international 2008;102(2):253-8.
2008: Gallina Andrea; Chun Felix K-H; Suardi Nazareno; Eastham James A; Perrotte Paul; Graefen Markus; Hutterer Georg; Huland Hartwig; Klein Eric A; Reuther Alwyn; Montorsi Francesco; Briganti Alberto; Shariat Shahrokh F; Roehrborn Claus G; de la Taille Alexandre; Salomon Laurent; Karakiewicz Pierre I
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Hellwinkel Olaf J C; Rogmann Jan-Peer; Asong Legrehndem E; Luebke Andreas M; Eichelberg Christian; Ahyai Sascha; Isbarn Hendrik; Graefen Markus; Huland Hartwig; Schlomm Thorsten
A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.
BJU international 2008;101(11):1454-60.
2008: Isbarn H; Budäus L; Pichlmeier U; Conrad S; Huland H; Friedrich M G
[Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder]
Der Urologe. Ausg. A 2008;47(5):608-15.
2008: Ahyai Sascha A; Graefen Markus; Steuber Thomas; Haese Alexander; Schlomm Thorsten; Walz Jochen; Köllermann Jens; Briganti Alberto; Zacharias Mario; Friedrich Martin G; Karakiewicz Pierre I; Montorsi Francesco; Huland Hartwig; Chun Felix K-H
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
European urology 2008;53(4):750-7.
2008: Karakiewicz Pierre I; Chun Felix K-H; Gallina Andrea; Suardi Nazareno; Briganti Alberto; Erbersdobler Andreas; Schlomm Thorsten; Walz Jochen; Currlin Eike; Michl Uwe; Haese Alexander; Arjane Philippe; Heinzer Hans; Graefen Markus; Huland Hartwig
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
Journal of endourology / Endourological Society 2008;22(3):533-8.
2008: Suardi Nazareno; Porter Christopher R; Reuther Alwyn M; Walz Jochen; Kodama Koichi; Gibbons Robert P; Correa Roy; Montorsi Francesco; Graefen Markus; Huland Hartwig; Klein Eric A; Karakiewicz Pierre I
A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
Cancer 2008;112(6):1254-63.
2008: Graefen M; Ahyai S; Heuer R; Salomon G; Schlomm T; Isbarn H; Budäus L; Heinzer H; Huland H
[Active surveillance for prostate cancer]
Der Urologe. Ausg. A 2008;47(3):261-9.
2008: Briganti Alberto; Gallina Andrea; Suardi Nazareno; Chun Felix K-H; Walz Jochen; Heuer Roman; Salonia Andrea; Haese Alexander; Perrotte Paul; Valiquette Luc; Graefen Markus; Rigatti Patrizio; Montorsi Francesco; Huland Hartwig; Karakiewicz Pierre I
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
BJU international 2008;101(5):556-60.
2008: Schlomm Thorsten; Näkel Esther; Lübke Andreas; Buness Andreas; Chun Felix K-H; Steuber Thomas; Graefen Markus; Simon Ronald; Sauter Guido; Poustka Annemarie; Huland Hartwig; Erbersdobler Andreas; Sültmann Holger; Hellwinkel Olaf J C
Marked gene transcript level alterations occur early during radical prostatectomy.
European urology 2008;53(2):333-44.
2007: Briganti Alberto; Chun Felix K-H; Suardi Nazareno; Gallina Andrea; Walz Jochen; Graefen Markus; Shariat Shahrokh; Ebersdobler Andreas; Rigatti Patrizio; Perrotte Paul; Saad Fred; Montorsi Francesco; Huland Hartwig; Karakiewicz Pierre I
Prostate volume and adverse prostate cancer features: fact not artifact.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2669-77.
2007: Gallina Andrea; Briganti Alberto; Chun Felix K-H; Walz Jochen; Hutterer Georg C; Erbersdobler Andreas; Eichelberg Christian; Schlomm Thorsten; Ahyai Sascha A; Perrotte Paul; Saad Fred; Montorsi Francesco; Huland Hartwig; Graefen Markus; Karakiewicz Pierre I
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
BJU international 2007;100(6):1249-53.
2007: Schlomm Thorsten; Kirstein Patrick; Iwers Liv; Daniel Birte; Steuber Thomas; Walz Jochen; Chun Felix H K; Haese Alexander; Kollermann Jens; Graefen Markus; Huland Hartwig; Sauter Guido; Simon Ronald; Erbersdobler Andreas
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6579-84.
2007: Gallina Andrea; Jeldres Claudio; Chun Felix K-H; Shariat Shahrokh F; Briganti Alberto; Walz Jochen; Roehrborn Claus G; Saad Fred; Huland Hartwig; Graefen Markus; Montorsi Francesco; Karakiewicz Pierre I
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
European urology 2007;52(5):1374-80.
2007: Chun Felix K-H; Briganti Alberto; Gallina Andrea; Hutterer Georg C; Shariat Shahrokh F; Antebie Elie; Walz Jochen; Roehrborn Claus G; Salonia Andrea; Rigatti Patrizio; Saad Fred; Huland Hartwig; Montorsi Francesco; Graefen Markus; Karakiewicz Pierre I
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
European urology 2007;52(4):1067-74.
2007: Friedrich Martin G; Pichlmeier Uwe; Schwaibold Hartwig; Conrad Stefan; Huland Hartwig
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
European urology 2007;52(4):1123-29.
2007: Briganti Alberto; Chun Felix K-H; Hutterer Georg C; Gallina Andrea; Shariat Shahrokh F; Salonia Andrea; Scattoni Vincenzo; Valiquette Luc; Montorsi Francesco; Rigatti Patrizio; Graefen Markus; Huland Hartwig; Karakiewicz Pierre I
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
European urology 2007;52(3):733-43.
2007: Gallina Andrea; Karakiewicz Pierre I; Hutterer Georg C; Chun Felix K-H; Briganti Alberto; Walz Jochen; Antebi Elie; Shariat Shahrokh F; Suardi Nazareno; Graefen Markus; Erbersdobler Andreas; Salonia Andrea; Rigatti Patrizio; Huland Hartwig; Montorsi Francesco
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
International journal of cancer. Journal international du cancer 2007;121(4):791-5.
2007: Chun Felix K-H; Briganti Alberto; Graefen Markus; Montorsi Francesco; Porter Christopher; Scattoni Vincenzo; Gallina Andrea; Walz Jochen; Haese Alexander; Steuber Thomas; Erbersdobler Andreas; Schlomm Thorsten; Ahyai Sascha A; Currlin Eike; Valiquette Luc; Heinzer Hans; Rigatti Patrizio; Huland Hartwig; Karakiewicz Pierre I
Development and external validation of an extended 10-core biopsy nomogram.
European urology 2007;52(2):436-44.
2007: Friedrich M G; Toma M I; Chun J K H F; Steuber T; Budäus L; Isbarn H; Huland H
[DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder]
Der Urologe. Ausg. A 2007;46(7):761-8.
2007: Gallina Andrea; Chun Felix K-H; Briganti Alberto; Shariat Shahrokh F; Montorsi Francesco; Salonia Andrea; Erbersdobler Andreas; Rigatti Patrizio; Valiquette Luc; Huland Hartwig; Graefen Markus; Karakiewicz Pierre I
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
European urology 2007;52(1):98-105.
2007: Gallina Andrea; Karakiewicz Pierre I; Chun Felix K-H; Briganti Alberto; Graefen Markus; Montorsi Francesco; Walz Jochen; Jeldres Claudio; Erbersdobler Andreas; Salonia Andrea; Suardi Nazareno; Dehò Federico; Schlomm Thorsten; Scattoni Vincenzo; Haese Alexander; Heinzer Hans; Valiquette Luc; Rigatti Patrizio; Huland Hartwig
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
BJU international 2007;99(6):1404-8.
2007: Briganti Alberto; Karakiewicz Pierre I; Chun Felix K-H; Gallina Andrea; Salonia Andrea; Zanni Giuseppe; Valiquette Luc; Graefen Markus; Huland Hartwig; Rigatti Patrizio; Montorsi Francesco
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
European urology 2007;51(6):1573-81.
2007: Chun Felix K-H; Graefen Markus; Briganti Alberto; Gallina Andrea; Hopp Julia; Kattan Michael W; Huland Hartwig; Karakiewicz Pierre I
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
European urology 2007;51(5):1236-40; discussion 1241-3.
2007: Chun Felix K-H; Karakiewicz Pierre I; Briganti Alberto; Walz Jochen; Kattan Michael W; Huland Hartwig; Graefen Markus
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
BJU international 2007;99(4):794-800.
2007: Briganti Alberto; Salonia Andrea; Gallina Andrea; Chun Felix K-H; Karakiewicz Pierre I; Graefen Markus; Huland Hartwig; Rigatti Patrizio; Montorsi Francesco
Management of erectile dysfunction after radical prostatectomy in 2007.
World journal of urology 2007;25(2):143-8.
2007: Chun Felix K-H; Karakiewicz Pierre I; Huland Hartwig; Graefen Markus
Role of nomograms for prostate cancer in 2007.
World journal of urology 2007;25(2):131-42.
2007: Schwarzenbach Heidi; Chun Felix K-H; Lange Imke; Carpenter Sebastian; Gottberg Miriam; Erbersdobler Andreas; Friedrich Martin G; Huland Hartwig; Pantel Klaus
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.
International journal of cancer. Journal international du cancer 2007;120(7):1465-71.
2007: Steuber Thomas; Vickers Andrew; Haese Alexander; Kattan Michael W; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
2007: Chun Felix K-H; Briganti Alberto; Jeldres Claudio; Erbersdobler Andreas; Schlomm Thorsten; Steuber Thomas; Gallina Andrea; Walz Jochen; Perrotte Paul; Huland Hartwig; Graefen Markus; Karakiewicz Pierre I
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
European urology 2007;51(4):949-55; discussion 955.
2007: Burchardt Martin; Huland Hartwig
Treatment of localized prostate cancer.
World journal of urology 2007;25(1):1-2.
2007: Stephan Carsten; Xu Chuanliang; Cammann Henning; Graefen Markus; Haese Alexander; Huland Hartwig; Semjonow Axel; Diamandis Eleftherios P; Remzi Mesut; Djavan Bob; Wildhagen Mark F; Blijenberg Bert G; Finne Patrik; Stenman Ulf-Hakan; Jung Klaus; Meyer Hellmuth-Alexander
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
World journal of urology 2007;25(1):95-103.
2007: Walz Jochen; Graefen Markus; Huland Hartwig
Basic principles of anatomy for optimal surgical treatment of prostate cancer.
World journal of urology 2007;25(1):31-8.
2007: Walz J; Graefen M; Michl U H G; Heinzer H; Friedrich M G; Eichelberg C; Haese A; Huland H
[Technical aspects of nerve sparing during retropubic prostatectomy]
Annales d'urologie 2007;41(1):23-30.
2007: Chun Felix K-H; Briganti Alberto; Graefen Markus; Porter Christopher; Montorsi Francesco; Haese Alexander; Scattoni Vincenzo; Borden Lester; Steuber Thomas; Salonia Andrea; Schlomm Thorsten; Latchemsetty Kalyan; Walz Jochen; Kim Jason; Eichelberg Christian; Currlin Eike; Ahyai Sascha A; Erbersdobler Andreas; Valiquette Luc; Heinzer Hans; Rigatti Patrizio; Huland Hartwig; Karakiewicz Pierre I
Development and external validation of an extended repeat biopsy nomogram.
The Journal of urology 2007;177(2):510-5.
2007: Chun Felix K-H; Briganti Alberto; Jeldres Claudio; Gallina Andrea; Erbersdobler Andreas; Schlomm Thorsten; Walz Jochen; Eichelberg Christian; Salomon Georg; Haese Alexander; Currlin Eike; Ahyai Sascha A; Bénard François; Huland Hartwig; Graefen Markus; Karakiewicz Pierre I
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 2007;43(3):536-43.
2007: Steuber Thomas; Vickers Andrew J; Serio Angel M; Vaisanen Ville; Haese Alexander; Pettersson Kim; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Clinical chemistry 2007;53(2):233-40.
2007: Chun Felix K H; Briganti Alberto; Graefen Markus; Erbersdobler Andreas; Walz Jochen; Schlomm Thorsten; Meschke Mirja; Haese Alexander; Valiquette Luc; Huland Hartwig; Karakiewicz Pierre I
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 2007;43(2):375-82.
2007: Eichelberg Christian; Erbersdobler Andreas; Michl Uwe; Schlomm Thorsten; Salomon Georg; Graefen Markus; Huland Hartwig
Nerve distribution along the prostatic capsule.
European urology 2007;51(1):105-10; discussion 110-1.
2007: Aalamian-Matheis Maryam; Chatta Gurkamal S; Shurin Michael R; Huland Edith; Huland Hartwig; Shurin Galina V
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA.
Advances in experimental medicine and biology 2007;601():173-82.
2006: Steuber Thomas; Chun Felix K-H; Erbersdobler Andreas; Briganti Alberto; Haese Alexander; Graefen Markus; Schlomm Thorsten; Valiquette Luc; Huland Hartwig; Karakiewicz Pierre I
Development and internal validation of preoperative transition zone prostate cancer nomogram.
Urology 2006;68(6):1295-300.
2006: Chun Felix K-H; Briganti Alberto; Antebi Elie; Graefen Markus; Currlin Eike; Steuber Thomas; Schlomm Thorsten; Walz Jochen; Haese Alexander; Friedrich Martin G; Ahyai Sascha A; Eichelberg Christian; Salomon Georg; Gallina Andrea; Erbersdobler Andreas; Perrotte Paul; Heinzer Hans; Huland Hartwig; Karakiewicz Pierre I
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
BJU international 2006;98(6):1204-9.
2006: Chun Felix K-H; Karakiewicz Pierre I; Briganti Alberto; Gallina Andrea; Kattan Michael W; Montorsi Francesco; Huland Hartwig; Graefen Markus
Prostate cancer nomograms: an update.
European urology 2006;50(5):914-26; discussion 926.
2006: Huland Hartwig
The case against extended lymph-node dissection for prostate cancer.
Nature clinical practice. Urology 2006;3(9):456-7.
2006: Chun Felix K-H; Müller Imke; Lange Imke; Friedrich Martin G; Erbersdobler Andreas; Karakiewicz Pierre I; Graefen Markus; Pantel Klaus; Huland Hartwig; Schwarzenbach Heidi
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.
BJU international 2006;98(3):544-8.
2006: Shariat Shahrokh F; Marberger Michael J; Lotan Yair; Sanchez-Carbayo Marta; Zippe Craig; Lüdecke Gerson; Boman Hans; Sawczuk Ihor; Friedrich Martin G; Casella Roberto; Mian Christine; Eissa Sanaa; Akaza Hideyuki; Serretta Vincenzo; Huland Hartwig; Hedelin Hans; Raina Rupesh; Miyanaga Naoto; Sagalowsky Arthur I; Roehrborn Claus G; Karakiewicz Pierre I
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
The Journal of urology 2006;176(3):919-26; discussion 926.
2006: Budäus L H; Wirth M P; Wolff J M; Bartsch G; Noldus J; Huland H
[100 years prostate cancer: yesterday--today--tomorrow]
Der Urologe. Ausg. A 2006;45 Suppl 4():122-6.
2006: Walz Jochen; Graefen Markus; Chun Felix K-H; Erbersdobler Andreas; Haese Alexander; Steuber Thomas; Schlomm Thorsten; Huland Hartwig; Karakiewicz Pierre I
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
European urology 2006;50(3):498-505.
2006: Chun Felix K-H; Briganti Alberto; Shariat Shahrokh F; Graefen Markus; Montorsi Francesco; Erbersdobler Andreas; Steuber Thomas; Salonia Andrea; Currlin Eike; Scattoni Vincenzo; Friedrich Martin G; Schlomm Thorsten; Haese Alexander; Michl Uwe; Colombo Renzo; Heinzer Hans; Valiquette Luc; Rigatti Patrizio; Roehrborn Claus G; Huland Hartwig; Karakiewicz Pierre I
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
BJU international 2006;98(2):329-34.
2006: Tilki D; Irmak S; Oliveira-Ferrer L; Hauschild J; Miethe K; Atakaya H; Hammerer P; Friedrich M G; Schuch G; Galalae R; Stief C G; Kilic E; Huland H; Ergun S
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer.
Oncogene 2006;25(36):4965-74.
2006: Chun Felix K-H; Graefen Markus; Zacharias Mario; Haese Alexander; Steuber Thomas; Schlomm Thorsten; Walz Jochen; Karakiewicz Pierre I; Huland Hartwig
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
World journal of urology 2006;24(3):273-80.
2006: Michl Uwe H G; Friedrich Martin G; Graefen Markus; Haese Alexander; Heinzer Hans; Huland Hartwig
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy.
The Journal of urology 2006;176(1):227-31.
2006: Eichelberg Christian; Erbersdobler Andreas; Haese Alexander; Schlomm Thorsten; Chun Felix K H; Currlin Eike; Walz Jochen; Steuber Thomas; Graefen Markus; Huland Hartwig
Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.
European urology 2006;49(6):1011-6; discussion 1016-8.
2006: Piironen Timo; Haese Alexander; Huland Hartwig; Steuber Thomas; Christensen Ib Jarle; Brünner Nils; Danø Keld; Høyer-Hansen Gunilla; Lilja Hans
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Clinical chemistry 2006;52(5):838-44.
2006: Karakiewicz Pierre I; Benayoun Serge; Zippe Craig; Lüdecke Gerson; Boman Hans; Sanchez-Carbayo Marta; Casella Roberto; Mian Christine; Friedrich Martin G; Eissa Sanaa; Akaza Hideyuki; Huland Hartwig; Hedelin Hans; Rupesh Raina; Miyanaga Naoto; Sagalowsky Arthur I; Marberger Michael J; Shariat Shahrokh F
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
BJU international 2006;97(5):997-1001.
2006: Chun Felix K-H; Steuber Thomas; Erbersdobler Andreas; Currlin Eike; Walz Jochen; Schlomm Thorsten; Haese Alexander; Heinzer Hans; McCormack Michael; Huland Hartwig; Graefen Markus; Karakiewicz Pierre I
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
European urology 2006;49(5):820-6.
2006: Hautmann S; Chun K H F; Currlin E; Braun P; Huland H; Juenemann K P
Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder: a comparative analysis for patients with bladder cancer.
The Journal of urology 2006;175(4):1389-93; discussion 1393-4.
2006: Steuber Thomas; Graefen Markus; Haese Alexander; Erbersdobler Andreas; Chun Felix K-H; Schlom Thorsten; Perrotte Paul; Huland Hartwig; Karakiewicz Pierre I
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
The Journal of urology 2006;175(3 Pt 1):939-44; discussion 944.
2006: Steuber Thomas; Vickers Andrew J; Haese Alexander; Becker Charlotte; Pettersson Kim; Chun Felix K-H; Kattan Michael W; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
2006: Chun Felix K-H; Briganti Alberto; Lebeau Thierry; Fradet Vincent; Steuber Thomas; Walz Jochen; Schlomm Thorsten; Eichelberg Christian; Haese Alexander; Erbersdobler Andreas; McCormack Michael; Perrotte Paul; Graefen Markus; Huland Hartwig; Karakiewicz Pierre I
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
European urology 2006;49(2):273-8; discussion 278-9.
2006: Steuber Thomas; Erbersdobler Andreas; Graefen Markus; Haese Alexander; Huland Hartwig; Karakiewicz Pierre I
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
Cancer 2006;106(4):775-82.
2006: Friedrich M G; Friedrich E; Graefen M; Heinzer H; Michl U; Huland H; Noldus J
[Success rates of two-layer, microsurgical vasovasostomy. Results from a patient questionnaire and comparison with one-layer technique]
Aktuelle Urologie 2006;37(1):58-63.
2006: Graefen Markus; Walz Jochen; Huland Hartwig
Open retropubic nerve-sparing radical prostatectomy.
European urology 2006;49(1):38-48.
2005: Friedrich Martin G; Chandrasoma Shahin; Siegmund Kimberly D; Weisenberger Daniel J; Cheng Jonathan C; Toma Marieta I; Huland Hartwig; Jones Peter A; Liang Gangning
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.
European journal of cancer (Oxford, England : 1990) 2005;41(17):2769-78.
2005: Graefen M; Salomon G; Currlin E; Eichelberg C; Schlomm T; Huland H
[Selection criteria for the expected management of localised prostate cancer]
Der Urologe. Ausg. A 2005;44(11):1277-8, 1280-6.
2005: Irmak Ster; Tilki Derya; Heukeshoven Jochen; Oliveira-Ferrer Leticia; Friedrich Martin; Huland Hartwig; Ergün Süleyman
Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.
Proteomics 2005;5(16):4296-304.
2005: Heinzer H; Heuer R; V Nordenflycht O; Eichelberg C; Friederich P; Goetz A E; Huland H
[Fast-track surgery in radical retropubic prostatectomy. First experiences with a comprehensive program to enhance postoperative convalescence]
Der Urologe. Ausg. A 2005;44(11):1287-93.
2005: Leuenroth Sven; Riethdorf Sabine; Erbersdobler Andreas; Riethdorf Lutz; Löning Thomas; Huland Hartwig; Friedrich Martin G
Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
BJU international 2005;96(4):553-7.
2005: Schlomm Thorsten; Luebke Andreas M; Sültmann Holger; Hellwinkel Olaf J C; Sauer Ulrich; Poustka Annemarie; David Kerstin A; Chun Felix K H; Haese Alexander; Graefen Markus; Erbersdobler Andreas; Huland Hartwig
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
International journal of oncology 2005;27(3):713-20.
2005: Graefen Markus; Walz Jochen; Chun K-H F; Schlomm Thorsten; Haese Alexander; Huland Hartwig
Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
European urology 2005;47(6):756-60.
2005: Karakiewicz Pierre I; Benayoun Serge; Kattan Michael W; Perrotte Paul; Valiquette Luc; Scardino Peter T; Cagiannos Ilias; Heinzer Hans; Tanguay Simon; Aprikian Armen G; Huland Hartwig; Graefen Markus
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Bostwick David G; Adolfsson Jan; Burke Harry B; Damber Jan-Erik; Huland Hartwig; Pavone-Macaluso Michele; Waters David J
Epidemiology and statistical methods in prediction of patient outcome.
Scandinavian journal of urology and nephrology. Supplementum 2005;(216):94-110.
2005: Shariat Shahrokh F; Zippe Craig; Lüdecke Gerson; Boman Hans; Sanchez-Carbayo Marta; Casella Roberto; Mian Christine; Friedrich Martin G; Eissa Sanaa; Akaza Hideyuki; Sawczuk Ihor; Serretta Vincenzo; Huland Hartwig; Hedelin Hans; Rupesh Raina; Miyanaga Naoto; Sagalowsky Arthur I; Wians Frank; Roehrborn Claus G; Lotan Yair; Perrotte Paul; Benayoun Serge; Marberger Michael J; Karakiewicz Pierre I
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2005: Meraney Anoop M; Haese Alexander; Palisaar Jüri; Graefen Markus; Steuber Thomas; Huland Hartwig; Klein Eric A
Surgical management of prostate cancer: advances based on a rational approach to the data.
European journal of cancer (Oxford, England : 1990) 2005;41(6):888-907.
2005: Steuber Thomas; Niemela Pauliina; Haese Alexander; Pettersson Kim; Erbersdobler Andreas; Felix Chun K-H; Graefen Markus; Kattan Michael W; Huland Hartwig; Lilja Hans
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
The Prostate 2005;63(1):13-8.
2005: Haese Alexander; Vaisanen Ville; Lilja Hans; Kattan Michael W; Rittenhouse Harry G; Pettersson Kim; Chan Daniel W; Huland Hartwig; Sokoll Lori J; Partin Alan W
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
The Journal of urology 2005;173(3):752-6.
2005: Steuber T; Karakiewicz P I; Augustin H; Erbersdobler A; Lange I; Haese A; Chun K-H F; Walz J; Graefen M; Huland H
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
The Journal of urology 2005;173(3):737-41.
2005: Palisaar Rein-Jüri; Noldus Joachim; Graefen Markus; Erbersdobler Andreas; Haese Alexander; Huland Hartwig
Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.
European urology 2005;47(2):176-84.
2004: Augustin Herbert; Erbersdobler Andreas; Hammerer Peter G; Graefen Markus; Huland Hartwig
Prostate cancers in the transition zone: Part 2; clinical aspects.
BJU international 2004;94(9):1226-9.
2004: Oliveira-Ferrer Leticia; Tilki Derya; Ziegeler Gudrun; Hauschild Jessica; Loges Sonja; Irmak Ster; Kilic Ergin; Huland Hartwig; Friedrich Martin; Ergün Süleyman
Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
Cancer research 2004;64(24):8932-8.
2004: Friedrich Martin G; Weisenberger Daniel J; Cheng Jonathan C; Chandrasoma Shahin; Siegmund Kimberly D; Gonzalgo Mark L; Toma Marieta I; Huland Hartwig; Yoo Christine; Tsai Yvonne C; Nichols Peter W; Bochner Bernard H; Jones Peter A; Liang Gangning
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7457-65.
2004: Panzer Ulf; Reinking Rüdiger R; Steinmetz Oliver M; Zahner Gunther; Sudbeck Ulrike; Fehr Susanne; Pfalzer Benjamin; Schneider André; Thaiss Friedrich; Mack Matthias; Conrad Stefan; Huland Hartwig; Helmchen Udo; Stahl Rolf A K
CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.
Transplantation 2004;78(9):1341-50.
2004: Hautmann Stefan; Toma Marieta; Lorenzo Gomez Maria Fernanda; Friedrich Martin G; Jaekel Torsten; Michl Uwe; Schroeder Gretchen L; Huland Hartwig; Juenemann Klaus-Peter; Lokeshwar Vinata B
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
European urology 2004;46(4):466-71.
2004: Schroeder Grethchen L; Lorenzo-Gomez Maria-Fernanda; Hautmann Stefan H; Friedrich Martin G; Ekici Sinan; Huland Hartwig; Lokeshwar Vinata
A side by side comparison of cytology and biomarkers for bladder cancer detection.
The Journal of urology 2004;172(3):1123-6.
2004: Huland Edith; Heinzer H; Jörres R A; Loppow D; Huland H
Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapy.
Der Urologe. Ausg. A 2004;43 Suppl 3():S140-4.
2004: Giessing M; Conrad S; Schönberger B; Huland H; Budde K; Neumayer H-H; Loening S A
[Kidney donors and kidney transplantation in the elderly]
Der Urologe. Ausg. A 2004;43(8):947-54.
2004: Haese Alexander; Graefen Markus; Huland Hartwig; Lilja Hans
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
Current urology reports 2004;5(3):231-40.
2004: Friedrich Martin G; Toma Marieta I; Petri Susan; Cheng Jonathan C; Hammerer Peter; Erbersdobler Andreas; Huland Hartwig
Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
European urology 2004;45(6):737-43.
2004: Toma Marieta I; Friedrich Martin G; Hautmann Stefan H; Jäkel K Thorsten; Erbersdobler Andreas; Hellstern Angelika; Huland Hartwig
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.
World journal of urology 2004;22(2):145-9.
2004: Hammerer P G; Augustin H; Blonski J; Graefen M; Haese A; Erbersdobler A; Daghofer F; Huland H
[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system]
Der Urologe. Ausg. A 2004;43(3):307-12.
2004: Hautmann S; Felix-Chun K-H; Currlin E; Friedrich M G; Dose Schwarz J; Langwieler T; Conrad S; Huland H
[Cystectomy for indications other than bladder cancer]
Der Urologe. Ausg. A 2004;43(2):172-7.
2004: Cagiannos Ilias; Karakiewicz Pierre; Graefen Markus; Eastham James A; Ohori Makoto; Rabbani Farhang; Reuter Victor; Wheeler Thomas; Kupelian Patrick; Klein Eric; Huland Hartwig; Hammerer Peter G; Erbersdobler Andreas; Schroeder Fritz; Wildhagen Mark; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Morash Christopher G; Scardino Peter T; Kattan Michael W
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: Michl U H G; Lange D; Graefen M; Huland H
Re: Intraoperative nerve stimulation with measurement of urethral sphincter pressure changes during radical retropubic prostatectomy: a feasibility study. C. P. Nelson, J. E. Montie, E. J. McGuire, G. Wedemeyer and J.T. Wei. J Urol, 169: 2225-2228, 2003.
The Journal of urology 2004;171(1):359; author reply 359.
2004: Graefen Markus; Ohori Makoto; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Henke Rolf-Peter; Huland Hartwig; Wheeler Thomas M; Slawin Kevin; Scardino Peter T; Kattan Michael W
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
2004: Augustin Herbert; Eggert Thilo; Wenske Sven; Karakiewicz Pierre I; Palisaar Jüri; Daghofer Fedor; Huland Hartwig; Graefen Markus
Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
The Journal of urology 2004;171(1):177-81.
2004: Hautmann Stefan; Friedrich Martin G; Fernandez Salvador; Steuber Thomas; Hammerer Peter; Braun Peter Martin; Jünemann Klaus-Peter; Huland Hartwig
Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal of small distal ureteral stones.
Urologia internationalis 2004;73(3):238-43.
2003: Haese Alexander; Graefen Markus; Steuber Thomas; Becker Charlotte; Noldus Joachim; Erbersdobler Andreas; Huland Edith; Huland Hartwig; Lilja Hans
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
The Journal of urology 2003;170(6 Pt 1):2269-73.
2003: Friedrich M G; Toma M I; Hellstern A; Pantel K; Weisenberger D J; Noldus J; Huland H
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer.
BJU international 2003;92(9):911-4.
2003: Heinzer H; Huland E; Huland H
[Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient]
Der Urologe. Ausg. A 2003;42(11):1450-2.
2003: Aalamian Maryam; Tourkova Irina L; Chatta Gurkamal S; Lilja Hans; Huland Edith; Huland Hartwig; Shurin Galina V; Shurin Michael R
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen.
The Journal of urology 2003;170(5):2026-30.
2003: Cagiannos Ilias; Karakiewicz Pierre; Eastham James A; Ohori Makato; Rabbani Farhang; Gerigk Claudia; Reuter Victor; Graefen Markus; Hammerer Peter G; Erbersdobler Andreas; Huland Hartwig; Kupelian Patrick; Klein Eric; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Morash Christopher G; Scardino Peter T; Kattan Michael W
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Kattan Michael W; Eastham James A; Wheeler Thomas M; Maru Norio; Scardino Peter T; Erbersdobler Andreas; Graefen Markus; Huland Hartwig; Koh Hideshige; Shariat Shahrokh F; Slawin Kevin M; Ohori Makoto
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Augustin Herbert; Hammerer Peter G; Graefen Markus; Palisaar Jüri; Daghofer Fedor; Huland Hartwig; Erbersdobler Andreas
Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy.
Journal of cancer research and clinical oncology 2003;129(11):662-8.
2003: Michl U; Graefen M; Noldus J; Eggert T; Huland H
[Functional results of various surgical techniques for radical prostatectomy]
Der Urologe. Ausg. A 2003;42(9):1196-202.
2003: Palisaar J; Eggert T; Graefen M; Haese A; Huland H
[Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications]
Der Urologe. Ausg. A 2003;42(9):1188-95.
2003: Haese A; Graefen M; Palisaar J; Huland E; Huland H
[Serum markers for early detection and staging of prostate cancer. Status report on current and future markers]
Der Urologe. Ausg. A 2003;42(9):1172-87.
2003: Augustin Herbert; Graefen Markus; Palisaar Jüri; Blonski Jakob; Erbersdobler Andreas; Daghofer Fedor; Huland Hartwig; Hammerer Peter G
Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2860-8.
2003: Augustin Herbert; Hammerer Peter G; Blonski Jakob; Graefen Markus; Palisaar Jüri; Daghofer Fedor; Huland Hartwig; Erbersdobler Andreas
Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?
Urology 2003;62(1):79-85.
2003: Aleman Michael; Karakiewicz Pierre I; Kupelian Patrick; Kattan Michael W; Graefen Markus; Cagiannos Ilias; Eastham James; Scardino Peter T; Huland Hartwig; Klein Eric A
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Graefen M; Augustin H; Karakiewicz P I; Hammerer P G; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino P T; Kattan M W; Huland H
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]
Der Urologe. Ausg. A 2003;42(5):685-92.
2003: Augustin Herbert; Hammerer Peter G; Graefen Markus; Erbersdobler Andreas; Blonski Jakob; Palisaar Jüri; Daghofer Fedor; Huland Hartwig
Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction.
European urology 2003;43(5):455-60.
2003: Friedrich M G; Hellstern A; Hautmann S H; Noldus I; Huland H
[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12]
Der Urologe. Ausg. A 2003;42(4):523-30.
2003: Augustin H; Erbersdobler A; Graefen M; Jaekel T; Haese A; Huland H; Hammerer P G
Differences in biopsy features between prostate cancers located in the transition and peripheral zone.
BJU international 2003;91(6):477-81.
2003: Augustin Herbert; Erbersdobler Andreas; Graefen Markus; Fernandez Salvador; Palisaar Jüri; Huland Hartwig; Hammerer Peter
Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
The Prostate 2003;55(1):48-54.
2003: Haese Alexander; Chaudhari Manisha; Miller M Craig; Epstein Jonathan I; Huland Hartwig; Palisaar Juri; Graefen Markus; Hammerer Peter; Poole Edward C; O'Dowd Gerard J; Partin Alan W; Veltri Robert W
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
Cancer 2003;97(4):969-78.
2003: Friedrich Martin G; Hellstern Angelika; Toma Marieta I; Hammerer Peter; Huland Hartwig
Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?
European urology 2003;43(2):146-50; discussion 150-1.
2003: Augustin Herbert; Hammerer Peter; Graefen Markus; Palisaar Jüri; Noldus Joachim; Fernandez Salvador; Huland Hartwig
Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002.
European urology 2003;43(2):113-8.
2003: Haese Alexander; Graefen Markus; Becker Charlotte; Noldus Joachin; Katz Jared; Cagiannos Ilias; Kattan Michael; Scardino Peter T; Huland Edith; Huland Hartwig; Lilja Hans
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
The Prostate 2003;54(3):181-6.
2003: Graefen Markus; Augustin Herbert; Karakiewicz Pierre I; Hammerer Peter G; Haese Alexander; Palisaar Juri; Blonski Jakob; Fernandez Salvator; Erbersdobler Andreas; Huland Hartwig
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.
European urology 2003;43(1):6-10; discussion 11.
2003: Huland E; Burger A; Fleischer J; Fornara P; Hatzmann E; Heidenreich A; Heinzer H; Heynemann H; Hoffmann L; Hofmann R; Huland H; Kämpfer I; Kindler M; Kirchner H; Mehlhorn G; Moniak T H; Rebmann U; Roigas J; Schneider T H; Schnorr D; Schmitz H J; Wenisch R; Varga Z; Vinke J
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.
Folia biologica 2003;49(5):183-90.
2002: Noldus Joachim; Graefen Markus; Huland Hartwig
Major postoperative complications secondary to use of the Bookwalter self-retaining retractor.
Urology 2002;60(6):964-7.
2002: Steuber Thomas; Nurmikko Paulina; Haese Alexander; Pettersson Kim; Graefen Markus; Hammerer Peter; Huland Hartwig; Lilja Hans
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
The Journal of urology 2002;168(5):1917-22.
2002: Haese Alexander; Epstein Jonathan I; Huland Hartwig; Partin Alan W
Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.
Cancer 2002;95(5):1016-21.
2002: Noldus Joachim; Michl Uwe; Graefen Markus; Haese Alexander; Hammerer Peter; Huland Hartwig
Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy.
European urology 2002;42(2):118-24.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Klein Eric; Kupelian Patrick; Skinner Donald G; Lieskovsky Gary; Bochner Bernard; Huland Hartwig; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Eastham James A; de Kernion Jean; Cangiano Thomas; Schröder Fritz H; Wildhagen Mark F; van der Kwast Theo H; Scardino Peter T; Kattan Michael W
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: Friedrich Martin G; Hellstern Angelika; Hautmann Stefan H; Graefen Markus; Conrad Stefan; Huland Edith; Huland Hartwig
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
The Journal of urology 2002;168(2):470-4.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Palisaar Jüri; Fernandez Salvador; Noldus Jochen; Erbersdobler Andreas; Huland Hartwig; Scardino Peter T; Kattan Michael W
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
2002: Huland E; Heinzer H; Timm S; Alamian M; Huland H
[Immunotherapy of metastatic renal cell carcinoma in Germany. An assessment of the current status]
Der Urologe. Ausg. A 2002;41(3):282-7.
2002: Heinzer H; Huland E; Huland H
[Regional immunotherapy of metastatic renal cell carcinoma]
Der Urologe. Ausg. A 2002;41(3):239-48.
2002: Cagiannos Ilias; Graefen Markus; Karakiewicz Pierre I; Ohori Makato; Eastham James A; Rabbani Farhang; Fair William; Wheeler Thomas M; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Huland Hartwig; Scardino Peter T; Kattan Michael W
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Stephan Miriam; Conrad Stefan; Eggert Thilo; Heuer Roman; Fernandez Salvador; Huland Hartwig
Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.
The Journal of urology 2002;167(3):1497-502.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Palisaar Jüri; Huland Edith; Scardino Peter T; Kattan Michael W; Huland Hartwig
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
2002: Huland Hartwig; Graefen Markus; Haese Alexander; Hammerer Peter G; Palisaar Juri; Pichlmeier Uwe; Henke Rolf-P; Erbersdobler Andreas; Huland Edith; Lilja Hans
Prediction of tumor heterogeneity in localized prostate cancer.
The Urologic clinics of North America 2002;29(1):213-22.
2002: Palisaar R Jüri; Graefen Markus; Karakiewicz Pierre I; Hammerer Peter G; Huland Edith; Haese Alexander; Fernandez Salvator; Erbersdobler Andreas; Henke Rolf-Peter; Huland Hartwig
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
European urology 2002;41(2):155-61.
2002: Conrad Stefan; Graefen Markus; Pichlmeier Uwe; Henke Rolf-Peter; Erbersdobler Andreas; Hammerer Peter G; Huland Hartwig
Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma.
The Journal of urology 2002;167(2 Pt 1):521-5.
2002: Erbersdobler Andreas; Fritz Henning; Schnöger Silvia; Graefen Markus; Hammerer Peter; Huland Hartwig; Henke R Peter
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
European urology 2002;41(1):40-6.
2002: Erbersdobler A; Huhle S; Palisaar J; Graefen M; Hammerer P; Noldus J; Huland H
Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone.
Prostate cancer and prostatic diseases 2002;5(4):279-84.
2001: Friedrich M G; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
European urology 2001;40(5):518-24.
2001: Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
The Prostate 2001;49(2):101-9.
2001: Heinzer H; Huland E; Huland H
Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer.
World journal of urology 2001;19(2):111-9.
2001: Shurin G V; Aalamian M; Pirtskhalaishvili G; Bykovskaia S; Huland E; Huland H; Shurin M R
Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors.
European urology 2001;39 Suppl 4():37-40.
2001: Prange W; Erbersdobler A; Hammerer P; Graefen M; Hautmann S H; Hautmann R E; Huland H; Henke R P
High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens.
European urology 2001;39 Suppl 4():30-1.
2001: Conrad S; Hautmann S H; Henke R P; Erbersdobler A; Simon J; Straub M; Graefen M; Hautmann R E; Huland H
Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients.
European urology 2001;39 Suppl 4():25-9.
2001: Reek C; Conrad S; Heinzer H; Huland H
[Side-fire laser coagulation of the prostate with the neodymium:YAG-laser. Long-term outcome]
Der Urologe. Ausg. A 2001;40(2):127-32.
2001: Hautmann S H; Schroeder G L; Civantos F; Duncan R C; Gnann R; Friedrich M G; Hellstern A; Huland H; Soloway M S; Lokeshwar V B
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]
Der Urologe. Ausg. A 2001;40(2):121-6.
2001: Noldus J; Michl U; Graefen M; Haese A; Hammerer P; Fernandez S; Huland H
[Nerve-sparing radical retropubic prostatectomy. Results of a patient survey]
Der Urologe. Ausg. A 2001;40(2):102-6.
2001: Prange W; Erbersdobler A; Hammerer P; Graefen M; Hautmann S H; Hautmann R E; Huland H; Henke R P
Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens.
Urology 2001;57(3):486-90.
2001: Graefen M; Haese A; Pichlmeier U; Hammerer P G; Noldus J; Butz K; Erbersdobler A; Henke R P; Michl U; Fernandez S; Huland H
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.
The Journal of urology 2001;165(3):857-63.
2001: Friedrich M G; Riethdorf S; Erbersdobler A; Tiemer C; Schwaibold H; Sölter J K; Huland E; Riethdorf L; Conrad S; Hammerer P G; Huland H
Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder.
European urology 2001;39(2):159-66.
2001: Aalamian M; Pirtskhalaishvili G; Nunez A; Esche C; Shurin G V; Huland E; Huland H; Shurin M R
Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells.
The Prostate 2001;46(1):68-75.
2000: Friedrich M G; Evans D; Noldus J; Huland H
The correction of penile curvature with the Essed-Schröder technique: a long-term follow-up assessing functional aspects and quality of life.
BJU international 2000;86(9):1034-8.
2000: Hammerer P; Graefen M; Henke R P; Haese A; Palisaar J; Huland E; Huland H
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy.
Anticancer research 2000;20(6D):5253-5.
2000: Wurmbach J H; Hammerer P; Sevinc S; Huland H; Ergün S
The expression of angiopoietins and their receptor Tie-2 in human prostate carcinoma.
Anticancer research 2000;20(6D):5217-20.
2000: Hautmann S; Huland E; Wullbrand A; Friedrich M; Huland H
Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.
Anticancer research 2000;20(6B):4495-8.
2000: Heinzer H; Huland E; Huland H
[Treatment of metastatic renal cell carcinoma. Value of immunotherapy compared with surgery of metastases]
Der Urologe. Ausg. A 2000;39(4):356-61.
2000: Hammerer P; Graefen M; Steuber T; Huland H
[Chemoprevention of prostatic carcinoma]
Der Urologe. Ausg. A 2000;39(4):304-8.
2000: Noldus J; Graefen M; Haese A; Henke R P; Hammerer P; Huland H
Stage migration in clinically localized prostate cancer.
European urology 2000;38(1):74-8.
2000: Hautmann S H; Conrad S; Henke R P; Erbersdobler A; Simon J; Straub M; Graefen M; Hautmann R E; Huland H
Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.
The Journal of urology 2000;163(6):1734-8.
2000: Graefen M; Hammerer P; Haese A; Huland H
[Therapeutic options in hormone refractory prostate carcinoma]
Der Urologe. Ausg. A 2000;39(3):267-73.
2000: Haese A; Becker C; Noldus J; Graefen M; Huland E; Huland H; Lilja H
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
The Journal of urology 2000;163(5):1491-7.
2000: Reek C; Tenschert W; Elsner H A; Kaulfers P M; Huland H
Pulsed-field gel electrophoresis for the analysis of Listeria monocytogenes infection clusters after kidney transplantation.
Urological research 2000;28(2):93-6.
2000: Friedrich M G; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
The Journal of urology 2000;163(3):1039-42.
2000: Huland E; Heinzer H; Huland H; Yung R
Overview of interleukin-2 inhalation therapy.
The cancer journal from Scientific American 2000;6 Suppl 1():S104-12.
2000: Huland E; Heinzer H; Huland H
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma.
Folia biologica 2000;46(6):241-50.
1999: Michl U H; Graefen M; Huland H
Re: A comparison of ureteroscopy to in situ extracorporeal shock wave lithotripsy for the treatment of distal ureteral calculi.
The Journal of urology 1999;162(6):2103-4.
1999: Lilja H; Haese A; Björk T; Friedrich M G; Piironen T; Pettersson K; Huland E; Huland H
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
The Journal of urology 1999;162(6):2029-34; discussion 2034-5.
1999: Heinzer H; Mir T S; Huland E; Huland H
Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3612-20.
1999: Heinzer H; Huland E; Aalamian M; Huland H
[Treatment of pulmonary metastases from kidney cell carcinoma with inhalational interleukin-2. 10-year experience Hamburger Unicenter]
Der Urologe. Ausg. A 1999;38(5):466-73.
1999: Huland E; Heinzer H; Huland H
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2).
Anticancer research 1999;19(4A):2679-83.
1999: Hautmann S H; Huland E; Huland H
Local intratumor immunotherapy of prostate cancer with interleukin-2 reduces tumor growth.
Anticancer research 1999;19(4A):2661-3.
1999: Haese A; Huland E; Graefen M; Huland H
Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.
Anticancer research 1999;19(4A):2641-4.
1999: Huland H; Noldus J
An easy and safe approach to separating Denonvilliers' fascia from rectum during radical retropubic prostatectomy.
The Journal of urology 1999;161(5):1533-4.
1999: Noldus J; Fernandez S; Huland H
Rectourinary fistula repair using the Latzko technique.
The Journal of urology 1999;161(5):1518-20.
1999: Reek C; Conrad S; Huland H
The role of C-reactive protein in graft dysfunction after renal transplantation.
The Journal of urology 1999;161(5):1463-6.
1999: Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
The Journal of urology 1999;161(4):1206-11.
1999: Fernandez De la Maza S; Noldus J; Huland H
[Ureterorenoscopy (URS) in treatment of ureteral calculi. II. Ureteroscopic treatment of calculus debris after ESWL]
Der Urologe. Ausg. A 1999;38(2):133-7.
1999: Fernandez De la Maza S; Noldus J; Huland H
[Ureterorenoscopy (URS) in treatment of ureteral calculi. I. Safety and effectiveness of URS as auxiliary treatment after ESWL]
Der Urologe. Ausg. A 1999;38(2):128-32.
1999: Reek C; Tenschert W; Cremaschi L; Conrad S; Fernandez S; Huland H
[Perioperative incidence of transfusions after allogenic kidney transplantation]
Der Urologe. Ausg. A 1999;38(1):38-41.
1999: Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
European urology 1999;36(1):21-30.
1998: Henke R P; Hammerer P; Graefen M; Erbersdobler A; Neumann M; Berger J; Huland H
Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma.
Cancer 1998;83(5):977-88.
1998: Schwaibold H; Friedrich M G; Fernandez S; Conrad S; Huland H
Improvement of ureteroileal anastomosis in continent urinary diversion with modified Le Duc procedure.
The Journal of urology 1998;160(3 Pt 1):718-20.
1998: Conrad S; Graefen M; Pichlmeier U; Henke R P; Hammerer P G; Huland H
Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma.
The Journal of urology 1998;159(6):2023-9.
1998: Noldus J; Graefen M; Huland E; Busch C; Hammerer P; Huland H
The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer.
The Journal of urology 1998;159(6):2004-7; discussion 2007-8.
1998: Lange I; Hammerer P; Knabbe C; Graefen M; Schmahl M; Huland H
[Plasma TGF-beta1 concentrations in patients with prostate carcinoma or benign prostatic hyperplasia]
Der Urologe. Ausg. A 1998;37(2):199-202.
1998: Noldus J; Graefen M; Hammerer P; Henke R P; Huland H
[Development of tumor selection based on pathological stage in clinically localized prostate carcinoma]
Der Urologe. Ausg. A 1998;37(2):195-8.
1998: Huland H
[What is the value of radical prostatectomy in lymph node positive prostate carcinoma?]
Der Urologe. Ausg. A 1998;37(2):138-40.
1998: Graefen M; Hammerer P; Michl U; Noldus J; Haese A; Henke R P; Huland E; Huland H
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy.
Urology 1998;51(3):437-42.
1998: Erbersdobler A; Friedrich M G; Schwaibold H; Henke R P; Huland H
Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
Oncology research 1998;10(8):415-20.
1998: Heinzer H; Hammerer P; Graefen M; Huland H
Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas.
European urology 1998;33(1):86-90.
1997: Huland E; Heinzer H; Mir T S; Huland H
Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience.
The cancer journal from Scientific American 1997;3 Suppl 1():S98-105.
1997: Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
The Journal of urology 1997;158(6):2188-92.
1997: Erbersdobler A; Hammerer P; Huland H; Henke R P
Numerical chromosomal aberrations in transition-zone carcinomas of the prostate.
The Journal of urology 1997;158(4):1594-8.
1997: Conrad S; Heinzer H; Fernandez de la Maza S; Schwaibold H; Huland H
[Long-term results of Stamey bladder neck suspension. Effect of data analysis technique on surgical result]
Der Urologe. Ausg. A 1997;36(5):432-9.
1997: Reek C; Tenschert W; Fernandez S; Meyer-Moldenhauer W H; Huland H
[Occurrence of lymphoceles after allogeneic kidney transplantation and their therapy]
Der Urologe. Ausg. A 1997;36(4):313-7.
1997: Conrad S; Pieper A; De la Maza S F; Busch R; Huland H
Long-term results of the Stamey bladder neck suspension procedure: a patient questionnaire based outcome analysis.
The Journal of urology 1997;157(5):1672-7.
1997: Lee E; Schwaibold H; Fradet Y; Huland E; Huland H
Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder.
The Journal of urology 1997;157(3):1070-3.
1997: Reek C; Noldus J; Huland H
[Experiences with local collagen injection in male stress incontinence]
Der Urologe. Ausg. A 1997;36(1):40-3; discussion 44.
1997: Hammerer P; Huland H
Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy.
The Journal of urology 1997;157(1):233-6.
1997: Hautmann S; Huland E; Huland H
Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in rats.
Journal of cancer research and clinical oncology 1997;123(11-12):614-8.
1997: Schölermann K H; Lauke H; Huland H; Hartmann M
Reinvestigation of patients after primary therapy of testicular tumor.
Advances in experimental medicine and biology 1997;424():77-8.
1997: Heinzer H; Graefen M; Noldus J; Hammerer P; Huland H
Early complication of anatomical radical retropubic prostatectomy: lessons from a single-center experience.
Urologia internationalis 1997;59(1):30-3.
1997: Noldus J; Hammerer P; Graefen M; Huland H
Surgical therapy for localized prostatic carcinoma.
Journal of cancer research and clinical oncology 1997;123(3):180-4.
1997: Schwaibold H; Pichlmeier U; Klingenberger H J; Huland H
Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
European urology 1997;31(2):153-9.
1996: Hammerer P; Michl U; Meyer-Moldenhauer W H; Huland H
Urethral closure pressure changes with age in men.
The Journal of urology 1996;156(5):1741-3.
1996: Huland H; Hammerer P; Henke R P; Huland E
Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
The Journal of urology 1996;155(4):1344-7.
1996: Huland H
The risks outweigh the benefits of radical prostatectomy in localised prostate cancer: the argument against.
European urology 1996;29 Suppl 2():31-3.
1995: Hammerer P; Henke R P; Hübner D; Huland H
[Preoperative assessment of tumor aggressiveness in localized prostatic carcinoma]
Der Urologe. Ausg. A 1995;34(5):413-8.
1995: Hammerer P; Hübner D; Gonnermann D; Huland H
[Perioperative and postoperative complications of pelvic lymphadenectomy and radical prostatectomy in 320 consecutive patients]
Der Urologe. Ausg. A 1995;34(4):334-42.
1995: Hammerer P; Huland H
[Value of determining prostate-specific antigen for early detection or prostatic carcinoma]
Der Urologe. Ausg. A 1995;34(4):283-9.
1995: Huland E; Schwaibold H; Klän R; Huland H
Long-term monitoring of 486P 3/12 antigen pattern (quantitative immunocytology) before, during, and after mitomycin C prophylaxis in patients with superficial bladder cancer.
Urology 1995;45(1):54-7; discussion 57-8.
1995: Conrad S; Gonnermann D; Heinzer H; Kabalin J N; Huland H
[Transurethral laser therapy of benign prostatic hyperplasia]
Der Urologe. Ausg. A 1995;34(1):25-34.
1995: Noldus J; Huland H
Dyeing: a simple method for detecting positive or negative surgical margins.
Urology 1995;45(1):133-5.
1995: Huland E; Falk B; Hübner D; Huland H
In vivo system to detect long-term continuous release of bioactive interleukin-2 by immunopharmacological depot preparations in nude mice with human tumors.
Journal of cancer research and clinical oncology 1995;121(5):285-90.
1995: Schwaibold H; Huland E; Heinzer H; Schwuléra U; Huland H
Toxicity of local, continuous and cyclic, high-dose bladder perfusion with recombinant and natural interleukin-2 in advanced cancer of the urinary bladder.
Journal of cancer research and clinical oncology 1995;121(4):239-46.
1995: Noldus J; Gonnermann D; Huland H
Autologous blood transfusion in radical prostatectomy: results in 263 patients.
European urology 1995;27(3):213-7.
1994: Hübner D; Henke R P; Hammerer P; Huland H
[Morphologic results of 106 consecutive radical prostatectomy specimen of patients with clinical stage B1-B3 (T2a-c) and histologically negative lymph nodes in the fossa obturatoria]
Der Urologe. Ausg. A 1994;33(6):497-504.
1994: Schwaibold H; Klingenberger H J; Huland H
[Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer]
Der Urologe. Ausg. A 1994;33(6):479-83.
1994: Henke R P; Krüger E; Ayhan N; Hübner D; Hammerer P; Huland H
Immunohistochemical detection of p53 protein in human prostatic cancer.
The Journal of urology 1994;152(4):1297-301.
1994: Conrad S; Schneider A W; Tenschert W; Meyer-Moldenhauer W H; Huland H
Endo-urological cold-knife incision for ureteral stenosis after renal transplantation.
The Journal of urology 1994;152(3):906-9.
1994: Noldus J; Ancker U; Schäfer H; Conrad S; Huland H
[Multilocular, giant angiomyolipoma of the kidney, adrenal gland and para-aortic lymph nodes. Case report of a 9-year-old boy with tuberous sclerosis]
Der Urologe. Ausg. A 1994;33(5):453-6.
1994: Conrad S; Schneider A W; Gonnermann D; Ganama A; Tenschert W; Huland H
[Urologic complications after kidney transplantation. Experiences in a center with 539 recipients]
Der Urologe. Ausg. A 1994;33(5):392-400.
1994: Huland H; Hübner D; Henke R P
Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, N0 prostatic carcinoma.
Urology 1994;44(2):211-4.
1994: Noldus J; Huland H
[Early complications of radical prostatectomy. Pelvic vein compression caused by wound drainage]
Der Urologe. Ausg. A 1994;33(2):172-4.
1994: Noldus J; Huland H
[Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?]
Der Urologe. Ausg. A 1994;33(1):73-5.
1994: Hammerer P; Huland H
Systematic sextant biopsies in 651 patients referred for prostate evaluation.
The Journal of urology 1994;151(1):99-102.
1994: Huland E; Heinzer H; Huland H
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment.
Journal of cancer research and clinical oncology 1994;120(4):221-8.
1993: Tenschert W; Gonnermann D; Meyer-Moldenhauer W H; Cremaschi L; Huland H
Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
Transplantation proceedings 1993;25(6):3256-8.
1993: Gross A J; Michael T; Godeman F; Weigel K; Huland H
Urological findings in patients with neurosurgically treated tethered spinal cord.
The Journal of urology 1993;149(6):1510-1.
1993: Huland H
[Pyelonephritic scar formation]
Der Urologe. Ausg. A 1993;32(1):16-21.
1992: Dieckmann K P; Huland H; Gross A J
A test for the identification of relevant sympathetic nerve fibers during nerve sparing retroperitoneal lymphadenectomy.
The Journal of urology 1992;148(5):1450-2.
1992: Heinzer H; Huland E; Mönk M; Huland H
Distribution of 486P 3/12 antigen, ABO(H) blood group antigen and T antigen in cystectomy specimens from patients with stage T2 transitional cell carcinoma of the bladder.
The Journal of urology 1992;148(3):802-5.
1992: Heinzer H; Huland E; Huland H
Adverse reaction to contrast material in a patient treated with local interleukin-2.
AJR. American journal of roentgenology 1992;158(6):1407.
1992: Knispel H H; Huland H
Influence of cause on choice of therapy in 174 patients with erectile dysfunction.
The Journal of urology 1992;147(5):1274-6.
1992: Hammerer P; Loy V; Dieringer J; Huland H
Prostate cancer in nonurological patients with normal prostates on digital rectal examination.
The Journal of urology 1992;147(3 Pt 2):833-6.
1992: Huland E; Huland H; Heinzer H
Interleukin-2 by inhalation: local therapy for metastatic renal cell carcinoma.
The Journal of urology 1992;147(2):344-8.
1992: Hammerer P; Huland H; Sparenberg A
Digital rectal examination, imaging, and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinoma.
European urology 1992;22(4):281-7.
1991: Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman H B; Hodges G M; Messing E M; Schmitz-Draeger B J
Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
The Journal of urology 1991;146(6):1631-6.
1991: Huland H
[Morphologic principles for radical prostatectomy]
Der Urologe. Ausg. A 1991;30(6):361-8; discussion 368-9.
1991: Hammerer P; Huland H
[Diagnosis of localized prostate cancer: screening and preoperative staging]
Der Urologe. Ausg. A 1991;30(6):378-86.
1991: Hammerer P; Huland H
[The diagnosis of prostatic carcinoma]
Fortschritte der Medizin 1991;109(26):512-7.
1991: Klän R; Loy V; Huland H
Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder.
The Journal of urology 1991;146(2):316-8.
1991: Klän R; Huland E; Baisch H; Huland H
Sensitivity of urinary quantitative immunocytology with monoclonal antibody 486 P3/12 in 241 unselected patients with bladder carcinoma.
The Journal of urology 1991;145(3):495-7.
1991: Conrad S; Busch R; Huland H
Complicated urinary tract infections.
European urology 1991;19 Suppl 1():16-22.
1991: Knispel H H; Gonnermann D; Huland H
Modified surgical technique to correct congenital and acquired penile curvature.
European urology 1991;20(2):107-12.
1990: Huland E; Huland H; Schneider A W
Quantitative immunocytology in the management of patients with superficial bladder carcinoma. I. A marker to identify patients who do not require prophylaxis.
The Journal of urology 1990;144(3):637-9; discussion 639-40.
1990: Dieckmann K P; Bornhoeft G; Huland H
[Ambulatory carboplatin monotherapy in advanced seminoma]
Der Urologe. Ausg. A 1990;29(5):281-5.
1990: Arndt R; Dittmer R; Harfmann P; Busch R; Heinzer H; Weiss M; Huland H
Virus detection by DNA in situ hybridization in renal transplantation--a new perspective for differential diagnosis of virus infection versus rejection.
Transplantation proceedings 1990;22(4):1803-4.
1990: Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
The Journal of urology 1990;144(1):68-71; discussion 71-2.
1990: Huland H
[Biological markers in urology]
Der Urologe. Ausg. A 1990;29(2):51.
1990: Schneider A W; Huland H
[Tumor markers and prognostic parameters in urinary bladder cancer]
Der Urologe. Ausg. A 1990;29(2):71-6.
1990: Gonnermann D; Huland H; Schweiker U; Oesterreich F U
Hydronephrotic atrophy after stable mild or severe partial ureteral obstruction: natural history and recovery after relief of obstruction.
The Journal of urology 1990;143(1):199-203.
1990: Otto U; Baisch H; Klöppel G; Huland H
Tumor heterogeneity of renal cell carcinoma.
European urology 1990;18 Suppl 2():38-9.
1989: Schneider A W; Huland E; Huland H
[Quantitative immunocytology as a marker for indications and follow-up of recurrence prevention of superficial urinary bladder cancers]
Der Urologe. Ausg. A 1989;28(5):289-91.
1989: Harfmann P; Dittmer R; Busch R; Arndt R; Krämer-Hansen H; Huland H
Renal transplantation using cyclosporine with and without regard to HLA matching: a randomized prospective unicenter study.
The Journal of urology 1989;142(3):691-3.
1988: Huland H; Gonnermann D; Werner B; Possin U
A new test to predict reversibility of hydronephrotic atrophy after stable partial unilateral ureteral obstruction.
The Journal of urology 1988;140(6):1591-4.
1988: Arndt R; Weiss M; Hammerer P; Huland H; Kruppa A; Krämer-Hansen H
Expression of immunoregulatory molecules on tubular cells and lymphocytes in fine-needle aspiration biopsy: early diagnostic marker for renal allograft rejection.
Transplantation proceedings 1988;20(4):614-6.
1988: Hammerer P; Krämer-Hansen H; Kremer B; Henne-Bruns D; Klöppel G; Arndt R; Huland H
Aspiration cytology of liver transplants.
Transplantation proceedings 1988;20(4):640-1.
1988: Arndt R; Heinzer H; Hammerer P; Huland H; Löhning T; Krämer-Hansen H
Identification of virus DNA in kidney transplants by fine-needle aspiration biopsy.
Transplantation proceedings 1988;20(4):581-3.
1988: Hammerer P; Arndt R; Krämer-Hansen H; Huland H; Klosterhalfen H
Consecutive selective aspiration cytology of renal cortex and renal medulla in kidney transplants.
Transplantation proceedings 1988;20(4):577-8.
1988: Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
European urology 1988;14(3):202-6.
1988: Huland H; Otto U; Arndt R; Huland E
Experimental studies on the heterogeneity of bladder carcinoma.
European urology 1988;14 Suppl 1():11-4.
1988: Arndt R; Hammerer P; Huland E; Krämer-Hansen H; Huland H
Treatment of acute cellular rejection in renal transplantation patients on ciclosporin with antithymocyte globulin.
Urologia internationalis 1988;43(3):139-44.
1985: Otto U; Huland H; Baisch H; Klöppel G
Transplantation of human renal cell carcinoma into NMRI nu/nu mice. III. Effect of irradiation on tumor acceptance and tumor growth.
The Journal of urology 1985;134(1):170-4.
1984: Otto U; Baisch H; Huland H; Klöppel G
Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma.
The Journal of urology 1984;132(2):237-9.
1984: Otto U; Huland H; Baisch H; Klöppel G
Transplantation of human renal cell carcinoma into NMRI nu/nu mice. II. Evaluation of response to vinblastine sulfate monotherapy.
The Journal of urology 1984;131(1):134-8.
1982: Otto U; Huland H; Klosterhalfen H
Evaluation of effective vinblastine-sulfate dosage in different renal cell carcinomas after transplantation to the NU/NU mice.
Progress in clinical and biological research 1982;100():209.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hartwig Huland

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hartwig Huland (preview)

All Publications